DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by DarioHealth Corp. on February 5, 2020. The filing documents the results of the Company's 2019 Special Meeting of Stockholders held on the same date. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbols DRIO (Common Stock) and DRIOW (Warrants).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity plan amendments rather than financial performance.
Material Changes
The primary material change reported is the stockholder approval of an amendment to the Company's Amended and Restated 2012 Equity Incentive Plan (the "2012 Plan Amendment").
- Share Authorization Increase: The number of shares authorized for issuance under the 2012 Plan was increased by 1,350,000 shares.
- New Total: The authorized share count rose from 618,650 to 1,968,650 shares.
- Eligibility: Officers and directors remain eligible to receive awards under the amended plan.
Voting Results and Management Commentary
Stockholders voted on Proposal No. 1 regarding the Incentive Plan Proposal. The proposal required the affirmative vote of a majority of stockholders entitled to vote and was approved. The final voting results were as follows:
| Vote Category | Number of Votes |
|---|---|
| For | 3,377,286 |
| Against | 200,341 |
| Abstain | 26,944 |
| Broker Non-Votes | 0 |
The filing does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies beyond the standard disclosure of the plan amendment.
Key Facts for Investor Verification
- Verify the impact of the 1,350,000 share increase on potential future dilution.
- Review the full text of the 2012 Plan Amendment (Exhibit 10.1) for specific terms regarding vesting and exercise conditions.
- Confirm the Company's current cash position and burn rate in subsequent filings (e.g., 10-Q or 10-K), as this 8-K does not address liquidity.